Luspatercept + Darbepoetin in MDS
Luspatercept + Darbepoetin in MDS
Recruiting · NCT07096297 · Registry updated 2026-09-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Luspatercept + Darbepoetin in MDS | Hemic and Lymphatic Diseases, anemia, bone marrow disorder, hematologic disorder, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia | Recruiting | Phase 2 | 2026-09-14 | NCT07096297 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Yale University | 458 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Harold C. Simmons Comprehensive Cancer Center of UT Southwestern | Dallas | United States | 1 |
| Robert H. Lurie Comprehensive Cancer Center of Northwestern University | Chicago | United States | 16 |
| The Ohio State University - The James Cancer Hospital and Solove Research Institute: Comprehensive Cancer Center ( | Columbus | United States | 1 |
| Yale University | New Haven | United States | 76 |